163 related articles for article (PubMed ID: 21416130)
1. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA.
Sakamoto A; Hayashi H; Sakamoto I; Isomoto I; Eguchi S; Takatsuki M; Kanematsu T; Abe K; Hayashi T; Uetani M
Abdom Imaging; 2012 Apr; 37(2):239-43. PubMed ID: 21416130
[TBL] [Abstract][Full Text] [Related]
2. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
3. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
[TBL] [Abstract][Full Text] [Related]
6. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
7. Gd-EOB-DTPA enhanced micro-MR imaging of hepatic tumors in H-ras 12V transgenic mice.
Bang DH; Park SH; Jun HY; Moon HB; Kim SU; Yu DY; Yoon KH
Acad Radiol; 2011 Jan; 18(1):13-9. PubMed ID: 20926317
[TBL] [Abstract][Full Text] [Related]
8. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.
Kitajima K; Yoshikawa T; Seo Y; Ohno Y; Yano Y; Miki A; Kanda T; Kanata N; Azuma T; Sugimura K
Magn Reson Imaging; 2011 May; 29(4):579-83. PubMed ID: 21216550
[TBL] [Abstract][Full Text] [Related]
9. [A case of hepatocellular carcinoma which could be diagnosed with Gd-EOB-DTPA enhanced MRI].
Ota H; Mikami K; Nagase A; Nagase H; Mukai R; Okada K; Ide Y; Maruyama K; Murata K; Yokouchi H; Tamai M; Kinuta M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2386-8. PubMed ID: 20037431
[TBL] [Abstract][Full Text] [Related]
10. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma.
Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kawai K; Kozaka K
J Comput Assist Tomogr; 2011; 35(2):181-6. PubMed ID: 21412087
[TBL] [Abstract][Full Text] [Related]
13. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.
Tamada T; Ito K; Yoshida K; Sone T; Murakami K; Kanki A; Watanabe S; Higashi H; Yamashita T
J Comput Assist Tomogr; 2010; 34(2):182-6. PubMed ID: 20351500
[TBL] [Abstract][Full Text] [Related]
14. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.
Tamada T; Ito K; Ueki A; Kanki A; Higaki A; Higashi H; Yamamoto A
J Magn Reson Imaging; 2012 Apr; 35(4):852-8. PubMed ID: 22127980
[TBL] [Abstract][Full Text] [Related]
15. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors.
Tsuda N; Kato N; Murayama C; Narazaki M; Yokawa T
Invest Radiol; 2004 Feb; 39(2):80-8. PubMed ID: 14734922
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
17. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia.
Cassiman D; Libbrecht L; Verslype C; Meersseman W; Troisi R; Zucman-Rossi J; Van Vlierberghe H
J Hepatol; 2010 Jul; 53(1):213-7. PubMed ID: 20447711
[TBL] [Abstract][Full Text] [Related]
18. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation.
Lerut JP; Ciccarelli O; Sempoux C; Danse E; deFlandre J; Horsmans Y; Sokal E; Otte JB
Transpl Int; 2003 Dec; 16(12):879-84. PubMed ID: 12904843
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
20. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
Tsuda N; Okada M; Murakami T
Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
